Showing results (41-50 of 77) with videos related to
Sort By:
Pageof 8
Journal of Translational Medicine|July 18, 2015
Scalable efficient expansion of mesenchymal stem cells in xeno free media using commercially available reagentsNeil H Riordan, Marialaura Madrigal, Jason Reneau, et al.Expert Opinion on Biological Therapy|January 16, 2008
Antigen-specific therapy of rheumatoid arthritisThomas E Ichim, Xiufen Zheng, Motohiko Suzuki, et al.Journal of Translational Medicine|August 5, 2010
Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditionsWan-Zhang Yang, Yun Zhang, Fang Wu, et al.Integrative Cancer Therapies|February 8, 2005
Orthomolecular oncology review: ascorbic acid and cancer 25 years laterMichael J González, Jorge R Miranda-Massari, Edna M Mora, et al.Journal of Translational Medicine|August 21, 2008
Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia?Michael P Murphy, Hao Wang, Amit N Patel, et al.Journal of Translational Medicine|November 17, 2007
Endometrial regenerative cells: a novel stem cell populationXiaolong Meng, Thomas E Ichim, Jie Zhong, et al.Bioengineering (Basel, Switzerland)|August 26, 2023
Comparison of Cost and Potency of Human Mesenchymal Stromal Cell Conditioned Medium Derived from 2- and 3-Dimensional CulturesMarialaura Madrigal, Patricia L Fernández, Ricardo Lleonart, et al.Puerto Rico Health Sciences Journal|September 21, 2004
Intravenous vitamin C as a chemotherapy agent: a report on clinical casesHugh D Riordan, Neil H Riordan, James A Jackson, et al.Journal of Translational Medicine|April 14, 2016
Safety of targeting tumor endothelial cell antigensSamuel C Wagner, Neil H Riordan, Thomas E Ichim, et al.Puerto Rico Health Sciences Journal|May 17, 2002
Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activityMichael J González, Jorge R Miranda-Massari, Edna M Mora, et al.Pageof 8